Trial Profile
A Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2012
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Johnson & Johnson Innovative Medicine
- 03 Aug 2012 Actual end date (5 Feb 2010) added as reported by European Clinical Trials Database.
- 01 Aug 2012 Company added in association field as reported by European Clinical Trials Database.
- 13 Jul 2012 Trial phase changed from III to IV as reported by ClinicalTrials.gov.